To nine cystic fibrosis patients with chronic bronchopulmonary infection of severely damaged lungs invaded by Pseudomonas aeruginosa, eleven courses of prolonged tobramycin treatment (5 mg/kg/day) for four to 16 weeks were administered. Pulmonary symptoms improved and a better quality of life was ac
Volumetric Capnography for the Evaluation of Pulmonary Disease in Adult Patients with Cystic Fibrosis and Noncystic Fibrosis Bronchiectasis
β Scribed by L. Veronez; M. M. Moreira; S. T. P. Soares; M. C. Pereira; M. A. G. O. Ribeiro; J. D. Ribeiro; R. G. G. Terzi; L. C. Martins; I. A. Paschoal
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 190 KB
- Volume
- 188
- Category
- Article
- ISSN
- 0341-2040
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Communicated by liirgm Horst Cystic fibrosis (CF) is caused by mutations in the gene for the cystic fibrosis transmembrane conductance regulator (CFTR) that codes for a CAMP-regulated chloride channel. The R347P is a missense mutation located within the first membrane spanning domain (MSD1) of
Airway inflammation and infection are present in patients with mild lung disease in cystic fibrosis (CF), suggesting the need for early treatment. In a previously reported large multicenter trial, dornase alfa improved pulmonary function and decreased the need for hospitalization in patients with CF
Serum ferritin (SF) levels are commonly elevated in patients with nonalcoholic fatty liver disease (NAFLD) because of systemic inflammation, increased iron stores, or both. The aim of this study was to examine the relationship between elevated SF and NAFLD severity. Demographic, clinical, histologic